Adherence to Long-Term Therapies - Evidence for Action
(2003; 211 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentAcknowledgements
View the documentScientific writers
View the documentIntroduction
View the documentTake-home messages
Open this folder and view contentsSection I - Setting the scene
Open this folder and view contentsSection II - Improving adherence rates: guidance for countries
Close this folderSection III - Disease-Specific Reviews
Open this folder and view contentsChapter VII - Asthma
Open this folder and view contentsChapter VIII - Cancer (Palliative care)
Open this folder and view contentsChapter IX - Depression
Open this folder and view contentsChapter X - Diabetes
Close this folderChapter XI - Epilepsy
View the document1. Introduction
View the document2. Adherence to epilepsy therapy
View the document3. Epidemiology of adherence
View the document4. Factors affecting adherence and interventions used to improve it
View the document5. Conclusions
View the document6. References
Open this folder and view contentsChapter XII - Human immunodeficiency virus and acquired immunodeficiency syndrome
Open this folder and view contentsChapter XIII - Hypertension
Open this folder and view contentsChapter XIV - Tobacco smoking cessation
Open this folder and view contentsChapter XV - Tuberculosis
Open this folder and view contentsAnnexes
Open this folder and view contentsWhere to find a copy of this book
 

6. References

1. Epilepsy: epidemiology, etiology and prognosis. Geneva, World Health Organization, 2001 (WHO Fact Sheet No 165; available on the Internet at http://www.who.int/inf-fs/en/fact165.html).

2. Chandra RS et al. Compliance monitoring in epileptic patients. Journal of the Association of Physicians of India, 1993, 41: 431 - 432.

3. French J. The long-term therapeutic management of epilepsy. Annals of Internal Medicine, 1994, 120: 411 - 422.

4. Kaiser C et al. Antiepileptic drug treatment in rural Africa: involving the community. Tropical Doctor, 1998, 28: 73 - 77.

5. Adamolekun B, Mielke JK, Ball DE. An evaluation of the impact of health worker and patient education on the care and compliance of patients with epilepsy in Zimbabwe. Epilepsia, 1999, 40: 507 - 511.

6. Garnett WR. Antiepileptic drug treatment: outcomes and adherence. Pharmacotherapy, 2000, 20: 191S - 199S.

7. Khurana DS. Treatment of status epilepticus. Indian Journal of Pediatrics, 2000, 67: S80 - S87.

8. Ogunniyi A, Oluwole OS, Osuntokun BO. Two-year remission in Nigerian epileptics. East African Medical Journal, 1998, 75: 392 - 395.

9. Lhatoo SD et al. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Epilepsia, 2000, 41: 1592 - 1596.

10. Sureka RK. Clinical profile and spectrum of epilepsy in rural Rajasthan. Journal of the Association of Physicians of India, 1999, 47: 608 - 610.

11. Gomes M, Maia FH, Noe RA. Anti-epileptic drug intake adherence. The value of the blood drug level measurement and the clinical approach. Arquivos de Neuro-Psiquiatria, 1998, 56: 708 - 713.

12. Hargrave R, Remler MP. Noncompliance. Journal of the National Medical Association, 1996, 88: 7.

13. Gomes M, Maia FH. Medication-taking behavior and drug self regulation in people with epilepsy. Arquivos de Neuro-Psiquiatria, 1998, 56: 714 - 719.

14. Mitchell WG, Scheier LM, Baker SA. Adherence to treatment in children with epilepsy: who follows "doctor's orders"? Epilepsia, 2000, 41: 1616 - 1625.

15. Snodgrass SR, Parks BR. Anticonvulsant blood levels: historical review with a pediatric focus. Journal of Child Neurology, 2000, 15: 734 - 746.

16. Yuen HK. Increasing medication compliance in a woman with anoxic brain damage and partial epilepsy. American Journal of Occupational Therapy, 1993, 47: 30 - 33.

17. Gledhill RF. In the shadow of epilepsy. Lancet, 1997, 350: 811.

18. Dowse R, Futter WT. Outpatient compliance with theophylline and phenytoin therapy. South African Medical Journal, 1991, 80: 550 - 553.

19. Leppik IE. How to get patients with epilepsy to take their medication. The problem of noncompliance. Postgraduate Medicine, 1990, 88: 253 - 256.

20. Buck D et al. Factors influencing compliance with antiepileptic drug regimes. Seizure, 1997, 6: 87 - 93.

21. Lannon SL. Using a health promotion model to enhance medication compliance. Journal of Neuroscience Nursing, 1997, 29: 170 - 178.

22. Cramer JA et al. How often is medication taken as prescribed? A novel assessment technique. Journal of the American Medical Association, 1989, 261: 3273 - 3277 [erratum published in Journal of the American Medical Association, 1989, 262: 1472].

23. Alonso NB, Da Silva DF, de Campos CJ. [Compliance in epilepsy. I. Concept factors and influence factors.] [Portuguese] Arquivos de Neuro-Psiquiatria, 1991, 49: 147 - 149.

24. Anonymous. Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Canadian Study Group for Childhood Epilepsy. Epilepsia, 1998, 39: 952 - 959.

25. Valodia P et al. Benefits of a clinical pharmacokinetic service in optimising phenytoin use in the western Cape. South African Medical Journal, 1998, 88: 873 - 875.

26. Dilorio C, Henry M. Self-management in persons with epilepsy. Journal of Neuroscience Nursing, 1995, 27: 338 - 343.

27. Elechi CA. Default and non-compliance among adult epileptics in Zaria, Nigeria. The need to restructure continued care. Tropical & Geographical Medicine, 1991, 43: 242 - 245.

28. Snodgrass SR et al. Pediatric patients with undetectable anticonvulsant blood levels: comparison with compliant patients. Journal of Child Neurology, 2001, 16: 164 - 168.

29. Hazzard A, Hutchinson SJ, Krawiecki N. Factors related to adherence to medication regimens in pediatric seizure patients. Journal of Pediatric Psychology, 1990, 15: 543 - 555.

30. Cloyd JC et al. Comparison of sprinkle versus syrup formulations of valproate for bioavailability, tolerance, and preference. Journal of Pediatrics, 1992, 120: 634 - 638.

31. Alonso NB et al. [Compliance in epilepsy. II. Practical aspects.] [Portuguese] Arquivos de Neuro-Psiquiatria, 1991, 49: 150 - 154.

32. Cramer JA. Medication compliance in epilepsy. Archives of Internal Medicine, 1991, 151: 1236 - 1237.

33. Desai P et al. Knowledge, attitudes and practice of epilepsy: experience at a comprehensive rural health services project. Seizure, 1998, 7: 133 - 138.

34. Buchanan N. Noncompliance with medication amongst persons attending a tertiary referral epilepsy clinic: implications, management and outcome. Seizure, 1993, 2: 79 - 82.

35. Abduljabbar M et al. Epilepsy classification and factors associated with control in Saudi adult patients. Seizure, 1998, 7: 501 - 504.

36. Mullen PD. Compliance becomes concordance. British Medical Journal, 1997, 314: 691 - 692.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: August 29, 2014